Home>>Signaling Pathways>> PI3K/Akt/mTOR Signaling>> Akt>>AKT-IN-6

AKT-IN-6 Sale

目录号 : GC62190

AKT-IN-6是一种强效的泛AKT(Akt1/2/3)小分子抑制剂,体外对三种AKT亚型的IC50均小于500nM。

AKT-IN-6 Chemical Structure

Cas No.:1430056-54-4

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥846.00
现货
5mg
¥765.00
现货
10mg
¥1,260.00
现货
25mg
¥2,520.00
现货
50mg
¥4,050.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

AKT-IN-6 is a potent pan‑AKT (Akt1/2/3) small molecule inhibitor with an in vitro IC50 of less than 500nM for all three AKT isoforms [1]. AKT-IN-6 is primarily used to study the regulation of AKT activity in the PI3K/Akt/mTOR signaling pathway and its role in disease models such as cancer and metabolic diseases [2-3].

In tilapia S. agalactiae infection model, Treatment with AKT-IN-6 (1mg/kg; ip; 2d) significantly reduced the expression and phosphorylation levels of IKKα/β, IκBα, and NF-κB p65 [4].

References:
[1]. Huang T, Feng H, Kong L, et al. Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors. United States patent US 8,895,571. 2014 Nov 25.
[2]. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007 Jun 29; 129(7): 1261-1274.
[3]. Castro D, Castaner R, Fernandez-Forner D. NME Digest-January 2016. Drugs of the Future. 2016; 41(1).
[4]. Mu L, Li J, Lin Z, et al. MBL regulates phagocytosis and bactericidal activity of macrophages by triggering AKT/NF-κB/Rab5A axis occurred early in vertebrate evolution. The Journal of Immunology. 2025 Apr 25: vkaf028.

AKT-IN-6是一种强效的泛AKT(Akt1/2/3)小分子抑制剂,体外对三种AKT亚型的IC50均小于500nM [1]。AKT-IN-6主要用于研究PI3K/Akt/mTOR信号通路中AKT活性的调控及其在癌症和代谢性疾病等疾病模型中的作用 [2-3]

在罗非鱼的S. agalactiae感染模型中,AKT-IN-6(1mg/kg;op;2d)治疗显著降低了IKKα/β、IκBα和NF-κB p65的表达和磷酸化水平 [4]

实验参考方法

Animal experiment [1]:

Animal models

Tilapia S. agalactiae infection model

Preparation Method

Tilapia were intraperito neally injected with 1mg/kg AKT-IN-6 or IKK-16 during S. agalactiae (1×107CFU/mL) infection before the separation of head kidney MA. MA from inhibitor-treated or untreated tilapia were challenged with OnMBL for 12h, and the phosphorylation levels of indicated molecules were detected by Western blot. In addition, the phagocytic ability and ROS release levels of MA in the AKT-IN-6 treatment group were analyzed by flow cytometry. For the survival assay, tilapia were intraperitoneally injected with 1mg/kg AKT-IN-6 for 2 consecutive days. During this time, fish were also infected with 100μL of S. agalactiae (1×108CFU/mL) in the absence or presence of OnMBL at 24h after the first inhibitor injection. The daily deaths of tilapia were recorded.

Dosage form

1mg/kg; ip; 2d

Applications

Treatment with AKT-IN-6 significantly reduced the expression and phosphorylation levels of IKKα/β, IκBα, and NF-κB p65.

References:
[1]. Mu L, Li J, Lin Z, et al. MBL regulates phagocytosis and bactericidal activity of macrophages by triggering AKT/NF-κB/Rab5A axis occurred early in vertebrate evolution. The Journal of Immunology. 2025 Apr 25: vkaf028.

化学性质

Cas No. 1430056-54-4 SDF
分子式 C22H20FN5O 分子量 389.43
溶解度 DMSO : 125 mg/mL (320.98 mM; Need ultrasonic) 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.5679 mL 12.8393 mL 25.6786 mL
5 mM 0.5136 mL 2.5679 mL 5.1357 mL
10 mM 0.2568 mL 1.2839 mL 2.5679 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: